A novel endogenous human CaMKII inhibitory protein suppresses tumor growth by inducing cell cycle arrest via p27 stabilization
about
Structure of the CaMKIIdelta/calmodulin complex reveals the molecular mechanism of CaMKII kinase activationThe emerging role of CaMKII in cancerGlobal analysis of gene expression changes during retinoic acid-induced growth arrest and differentiation of melanoma: comparison to differentially expressed genes in melanocytes vs melanomaNovel biomarkers for prostate cancer including noncoding transcripts.Integrated analysis of mutations, miRNA and mRNA expression in glioblastoma.Potentiation of tumor necrosis factor-alpha-induced tumor cell apoptosis by a small molecule inhibitor for anti-apoptotic protein hPEBP4Human phosphatidylethanolamine-binding protein 4 promotes transactivation of estrogen receptor alpha (ERalpha) in human cancer cells by inhibiting proteasome-dependent ERalpha degradation via association with Src.Oxaliplatin induces different cellular and molecular chemoresistance patterns in colorectal cancer cell lines of identical originsIdentification of differentially-expressed genes by DNA methylation in cervical cancer.The growth and aggressive behavior of human osteosarcoma is regulated by a CaMKII-controlled autocrine VEGF signaling mechanismUpregulation of T-cell factor-4 isoform-responsive target genes in hepatocellular carcinoma.Inhibitory effect of NBL1 on PDGF-BB-induced human PASMC proliferation through blockade of PDGFβ-p38MAPK pathway.Endogenous human CaMKII inhibitory protein suppresses tumor growth by inducing cell cycle arrest and apoptosis through down-regulation of the phosphatidylinositide 3-kinase/Akt/HDM2 pathway.Fbxl12 triggers G1 arrest by mediating degradation of calmodulin kinase I.RNA sequencing (RNA-Seq) of lymph node, spleen, and thymus transcriptome from wild Peninsular Malaysian cynomolgus macaque (Macaca fascicularis).Early dynamic transcriptomic changes during preoperative radiotherapy in patients with rectal cancer: a feasibility study.RUNX3 and CAMK2N1 hypermethylation as prognostic marker for epithelial ovarian cancer.Kv3.4 potassium channel-mediated electrosignaling controls cell cycle and survival of irradiated leukemia cells.Ca(2+)/calmodulin-dependent protein kinase II promotes cell cycle progression by directly activating MEK1 and subsequently modulating p27 phosphorylation.Ca2+/calmodulin-dependent protein kinase II regulates colon cancer proliferation and migration via ERK1/2 and p38 pathways.Nalmefene attenuates malignant potential in colorectal cancer cell via inhibition of opioid receptor.Functional Analyses of RUNX3 and CaMKIINα in Ovarian Cancer Cell Lines Reveal Tumor-Suppressive Functions for CaMKIINα and Dichotomous Roles for RUNX3 Transcript Variants.Literature and patent analysis of the cloning and identification of human functional genes in China.Loss of control over the ethanol consumption: differential transcriptional regulation in prefrontal cortex.Network analysis of UBE3A/E6AP-associated proteins provides connections to several distinct cellular processes.Tat peptide-calmodulin binding studies and bioinformatics of HIV-1 protein-calmodulin interactions.
P2860
10bc57b7208dfeb2de480761459198650f97fb74332ac8d7204727d742cba371dc7554084c69510445172650362b385db76201e0366763df56f79a4753b555f21063f07a69777656618c331d0cde5cce583c73195db828f5d52709ae9ee50be0125aac925e0e364b4ac42556ff4360eb3f3af294ccbc83aa93a8865446347e1fb648a52e56e838df0c55bdc09dcc54deb93b59eab716af46899738bdcb84fd92b17911c4e6af481c7940e42729d496430a21cfebb2eb38863457e5b3f9a18a2daf8a89a2f403f425c87d7e6360acbc581d232f7606b6514122e2fff0f3cdca0647a7b1d96c9c2767dc7c5bf45220f368
P248
Q24293502-9467D844-43CB-497C-B440-4D3208703F2EQ26995205-1DFBF29B-58E6-402B-A808-76D30163D5C8Q33375218-C47C362A-6BC9-4D24-9703-6FE2882E94A9Q33515231-8064D60F-A99A-4B12-8968-B4CD254E30A4Q33757859-31CA25EF-84CD-4B69-A551-33E630E082F3Q33782589-400D4AE9-2268-4168-9A66-30A9712C7A25Q33991159-BCBAC729-5EC0-45FC-9A24-3E2E67F9164DQ34831682-71B623B8-8F5C-431C-8432-E384CA41EB07Q35167558-1B014F58-EB5F-473B-A7AD-1531A116D543Q35362682-44310A65-ADB3-4BFF-923B-DAAAE028D10EQ36997259-26F7FEA6-939D-40AA-8CF9-7A8EB331DFCCQ37220791-B4440AF8-0302-4278-B4A7-47F4BAFC2135Q37375646-FB2382C8-6F52-4BF6-8328-7E017C94569BQ37527678-D6644A1D-E546-4353-AC6D-843823B0BAD2Q38429559-0DB402F4-D367-4AE2-A7BB-C487B0CC6678Q38489314-09AD2455-E68C-4BB8-8551-71C24F2FFC04Q38852995-4EB14DE1-9486-4DE6-89B9-F5D7C8B75D75Q39188078-1FF1918D-8AA4-4A1E-897B-B4F4AE333322Q39908743-352DC180-5F2C-4A77-947F-483031DB9020Q42058113-CFEB026F-2516-4D6D-A619-917F4C32822DQ47265006-8C5F62DC-EA52-4CEF-B153-9BB4DBF0495EQ47552260-4445A732-4CB6-427D-AFA4-18B09C9FE592Q47863989-66B73F5E-E41E-4433-8F69-20388FB76CAFQ47969369-32B44C5D-1B2E-424F-86E2-15CBCA0AA95AQ50095662-60FB429F-C169-4FCD-BCD7-6D5F6DB2311BQ51570059-A6850E2D-4991-478A-A5E7-DF1A4D71967D
P2860
A novel endogenous human CaMKII inhibitory protein suppresses tumor growth by inducing cell cycle arrest via p27 stabilization
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
A novel endogenous human CaMKI ...... e arrest via p27 stabilization
@ast
A novel endogenous human CaMKI ...... e arrest via p27 stabilization
@en
type
label
A novel endogenous human CaMKI ...... e arrest via p27 stabilization
@ast
A novel endogenous human CaMKI ...... e arrest via p27 stabilization
@en
prefLabel
A novel endogenous human CaMKI ...... e arrest via p27 stabilization
@ast
A novel endogenous human CaMKI ...... e arrest via p27 stabilization
@en
P2093
P2860
P921
P356
P1476
A novel endogenous human CaMKI ...... e arrest via p27 stabilization
@en
P2093
Chunmei Wang
Xingguang Liu
Xuetao Cao
Yuanyuan Zheng
P2860
P304
11565-11574
P356
10.1074/JBC.M800436200
P407
P577
2008-02-27T00:00:00Z